publicationMetadata:
  pmid: "32419643"
  title: "Long Noncoding RNA WT1-AS Inhibit Cell Malignancy via miR-494-3p in Glioma."
  queryType: "bench"
  publicationType: "Lab Research"
  publicationTypeConfidence: 1.0
  hasMethodsSection: Yes
  likelyContainsTools: Yes
  expectedToolTypes: |
    Lab Research → antibodies, cell lines, animal models, genetic reagents, computational tools, organoids, PDX
    
    This is a molecular biology study investigating long noncoding RNA WT1-AS and miR-494-3p in glioma.
    The study uses cell culture, transfection, qRT-PCR, Western blot, and other molecular techniques.
    Expected tools include: cell lines (multiple glioma cell lines mentioned), antibodies (for Western blot),
    genetic reagents (plasmids, miRNA constructs), and computational tools (bioinformatics analysis).
  overallAssessment: |
    This is a typical laboratory research study that extensively uses molecular biology tools and techniques.
    The study involves cell culture experiments, transfections, gene expression analysis, protein analysis,
    and functional assays. Multiple research tools should be present including cell lines, antibodies,
    genetic reagents, and computational tools. The absence of mined tools suggests significant under-mining.

toolValidations: []

potentiallyMissedTools:
  - toolName: "M059J"
    toolType: "cell_line"
    foundIn: "methods"
    contextSnippet: "Primary normal human astrocytes (M059J) and 4 glioma cell lines (U87, U118, U251, and A172) were commercially procured from Shanghai Cell Bank"
    whyMissed: "Standard cell line name not captured by mining patterns"
    confidence: 0.95
    shouldBeAdded: Yes

  - toolName: "U87"
    toolType: "cell_line"
    foundIn: "methods"
    contextSnippet: "4 glioma cell lines (U87, U118, U251, and A172) were commercially procured from Shanghai Cell Bank of the Chinese Academy of Sciences"
    whyMissed: "Common glioma cell line name not captured"
    confidence: 0.95
    shouldBeAdded: Yes

  - toolName: "U118"
    toolType: "cell_line"
    foundIn: "methods"
    contextSnippet: "4 glioma cell lines (U87, U118, U251, and A172) were commercially procured from Shanghai Cell Bank of the Chinese Academy of Sciences"
    whyMissed: "Common glioma cell line name not captured"
    confidence: 0.95
    shouldBeAdded: Yes

  - toolName: "U251"
    toolType: "cell_line"
    foundIn: "methods"
    contextSnippet: "4 glioma cell lines (U87, U118, U251, and A172) were commercially procured from Shanghai Cell Bank of the Chinese Academy of Sciences"
    whyMissed: "Common glioma cell line name not captured"
    confidence: 0.95
    shouldBeAdded: Yes

  - toolName: "A172"
    toolType: "cell_line"
    foundIn: "methods"
    contextSnippet: "4 glioma cell lines (U87, U118, U251, and A172) were commercially procured from Shanghai Cell Bank of the Chinese Academy of Sciences"
    whyMissed: "Common glioma cell line name not captured"
    confidence: 0.95
    shouldBeAdded: Yes

  - toolName: "pcDNA vector"
    toolType: "genetic_reagent"
    foundIn: "methods"
    contextSnippet: "The human lncRNA WT1-AS were cloned into plasmid cloning DNA (pcDNA) vector"
    whyMissed: "Standard molecular cloning vector not captured"
    confidence: 0.90
    shouldBeAdded: Yes

  - toolName: "lipofectamine 3000"
    toolType: "genetic_reagent"
    foundIn: "methods"
    contextSnippet: "Transfections were mediated as per the manufacturer's instruction for lipofectamine 3000 (Invitrogen, Carlsbad, CA, USA)"
    whyMissed: "Transfection reagent with vendor information not captured"
    confidence: 0.95
    shouldBeAdded: Yes

  - toolName: "TRIzol reagent"
    toolType: "genetic_reagent"
    foundIn: "methods"
    contextSnippet: "Total cellular RNA was extracted from glioma tissues and cultured cells using the commercially procured TRIzol reagent (Invitrogen)"
    whyMissed: "RNA extraction reagent with vendor not captured"
    confidence: 0.95
    shouldBeAdded: Yes

  - toolName: "Transcriptor First strand cDNA synthesis kit"
    toolType: "genetic_reagent"
    foundIn: "methods"
    contextSnippet: "RNA was reverse transcribed in to complementary DNA (cDNA) using the commercial Transcriptor First strand cDNA synthesis kit (Roche Diagnostics)"
    whyMissed: "Commercial kit with vendor information not captured"
    confidence: 0.95
    shouldBeAdded: Yes

  - toolName: "SYBR premix Extaq II kit"
    toolType: "genetic_reagent"
    foundIn: "methods"
    contextSnippet: "The quantitative real time polymerase chain reaction (qRT-PCR) was undertaken using the commercial SYBR premix Extaq II kit (Takara Inc, Dalian, China)"
    whyMissed: "qPCR reagent kit with vendor not captured"
    confidence: 0.95
    shouldBeAdded: Yes

  - toolName: "mirVana qRTPCR miRNA detection kit"
    toolType: "genetic_reagent"
    foundIn: "methods"
    contextSnippet: "mirVana qRTPCR miRNA detection kit (Ambion, Austin, Texas) were used to detect WT1-AS and miR-494-3p expression"
    whyMissed: "Specialized miRNA detection kit with vendor not captured"
    confidence: 0.95
    shouldBeAdded: Yes

  - toolName: "CCK-8 kit"
    toolType: "genetic_reagent"
    foundIn: "methods"
    contextSnippet: "Commercial kits were procured from Dojindo Molecular Technologies (CCK-8 kit, Shanghai, China)"
    whyMissed: "Cell proliferation assay kit with vendor not captured"
    confidence: 0.90
    shouldBeAdded: Yes

  - toolName: "EdU assay kit"
    toolType: "genetic_reagent"
    foundIn: "methods"
    contextSnippet: "Commercial kits were procured from Dojindo Molecular Technologies (CCK-8 kit, Shanghai, China) and Ribobio (EdU assay kit, Guangzhou, China)"
    whyMissed: "Cell proliferation assay kit with vendor not captured"
    confidence: 0.90
    shouldBeAdded: Yes

  - toolName: "p-AKT antibody"
    toolType: "antibody"
    foundIn: "methods"
    contextSnippet: "The membranes were incubated with antibodies against p-AKT, total AKT, and β-Actin (SantaCruz Biotechnology, Santa Cruz, USA)"
    whyMissed: "Antibody with vendor information not captured"
    confidence: 0.95
    shouldBeAdded: Yes

  - toolName: "total AKT antibody"
    toolType: "antibody"
    foundIn: "methods"
    contextSnippet: "The membranes were incubated with antibodies against p-AKT, total AKT, and β-Actin (SantaCruz Biotechnology, Santa Cruz, USA)"
    whyMissed: "Antibody with vendor information not captured"
    confidence: 0.95
    shouldBeAdded: Yes

  - toolName: "β-Actin antibody"
    toolType: "antibody"
    foundIn: "methods"
    contextSnippet: "The membranes were incubated with antibodies against p-AKT, total AKT, and β-Actin (SantaCruz Biotechnology, Santa Cruz, USA)"
    whyMissed: "Antibody with vendor information not captured"
    confidence: 0.95
    shouldBeAdded: Yes

  - toolName: "Ago2 antibody"
    toolType: "antibody"
    foundIn: "methods"
    contextSnippet: "Bound RNA and protein of interest is immunoprecipitated using the Ago2 antibody (Cell Signaling Technology, Beverly, MA, USA) at a dilution of 1:50"
    whyMissed: "Antibody with vendor and dilution information not captured"
    confidence: 0.95
    shouldBeAdded: Yes

  - toolName: "pmirGLO vector"
    toolType: "genetic_reagent"
    foundIn: "methods"
    contextSnippet: "The WT1-AS sequence including the putative binding sites of miR-494-3p was subcloned and then inserted into the pmirGLO vector (Promega, Madison, Wisconsin)"
    whyMissed: "Luciferase reporter vector with vendor not captured"
    confidence: 0.95
    shouldBeAdded: Yes

  - toolName: "DIANA Tools"
    toolType: "computational_tool"
    foundIn: "methods"
    contextSnippet: "Based on the prediction from DIANA Tools, miR-494-3p was predicted binding with WT1-AS"
    whyMissed: "Bioinformatics tool for miRNA target prediction not captured"
    confidence: 0.90
    shouldBeAdded: Yes

  - toolName: "SPSS"
    toolType: "computational_tool"
    foundIn: "methods"
    contextSnippet: "The statistical analyses were undertaken using a licensed version of SPSS (version 19.0, SPSS Inc, Chicago, IL, USA) compatible with Windows"
    whyMissed: "Statistical software with version and vendor information not captured"
    confidence: 0.95
    shouldBeAdded: Yes

suggestedPatterns:
  - patternType: "naming_convention"
    pattern: "\\b[A-Z][0-9]{2,4}[A-Z]?\\b"
    toolType: "cell_line"
    examples: ["U87", "U118", "U251", "A172", "M059J"]
    reasoning: "Cell line names often follow alphanumeric patterns with capital letters and numbers. This pattern would catch many standard cell line nomenclatures."

  - patternType: "context_phrase"
    pattern: "antibodies? against ([A-Za-z0-9-]+)"
    toolType: "antibody"
    examples: ["antibodies against p-AKT", "antibodies against total AKT", "antibodies against β-Actin"]
    reasoning: "The phrase 'antibodies against' followed by a protein name is a strong indicator of antibody usage in Western blot or immunoassays."

  - patternType: "vendor_indicator"
    pattern: "\\(([A-Za-z\\s]+),\\s*[A-Za-z\\s,]+\\)"
    toolType: "general"
    examples: ["(Invitrogen, Carlsbad, CA, USA)", "(SantaCruz Biotechnology, Santa Cruz, USA)", "(Cell Signaling Technology, Beverly, MA, USA)"]
    reasoning: "Vendor information in parentheses with company name and location is a strong indicator of commercial research tools."

  - patternType: "term"
    pattern: "\\b(TRIzol|lipofectamine|SYBR|mirVana|CCK-8|EdU)\\b"
    toolType: "genetic_reagent"
    examples: ["TRIzol reagent", "lipofectamine 3000", "SYBR premix", "mirVana qRTPCR", "CCK-8 kit", "EdU assay kit"]
    reasoning: "These are common molecular biology reagent names that should be captured as genetic reagents."

  - patternType: "context_phrase"
    pattern: "commercially? procured from ([A-Za-z\\s]+)"
    toolType: "general"
    examples: ["commercially procured from Shanghai Cell Bank", "procured from Dojindo Molecular Technologies"]
    reasoning: "The phrase 'procured from' followed by a company name indicates commercial research tools."

  - patternType: "term"
    pattern: "\\b(pcDNA|pmirGLO)\\s+vector"
    toolType: "genetic_reagent"
    examples: ["pcDNA vector", "pmirGLO vector"]
    reasoning: "Common molecular cloning vectors used in transfection experiments."

  - patternType: "context_phrase"
    pattern: "using\\s+(?:the\\s+)?([A-Za-z0-9\\s-]+)\\s+(?:kit|reagent|software|tool)"
    toolType: "general"
    examples: ["using the commercial SYBR premix Extaq II kit", "using TRIzol reagent"]
    reasoning: "The phrase 'using' followed by a tool name and type indicator is a strong usage context."

observations:
  - resourceName: "U87"
    resourceType: "Cell Line"
    observationType: "Cellular"
    observationTypeOntologyId: "MP:0005384"
    details: |
      WT1-AS overexpression significantly suppressed the proliferation of U87 cells as demonstrated by CCK-8 assay.
      EdU incorporation ratios were significantly lower in WT1-AS plasmid transfected U87 cells compared to control cells (P < 0.001).
      WT1-AS overexpression significantly inhibited U87 cell migration and invasion (P < 0.001).
      The proportion of viable U87 cells transfected with WT1-AS was significantly lower when treated with temozolomide compared to control cells.
      The IC50 value of temozolomide was significantly reduced in WT1-AS overexpression U87 cells (P < 0.01).
    foundIn: "results"
    contextSnippet: "The CCK-8 assay demonstrated that overexpression of WT1-AS significantly suppressed the proliferation of U87 and U373 cells... overexpression of WT1-AS significantly inhibited glioma cell migration and invasion"
    confidence: 0.95
    doi: "10.1177/1533033820919759"

  - resourceName: "U118"
    resourceType: "Cell Line"
    observationType: "Cellular"
    observationTypeOntologyId: "MP:0005384"
    details: |
      WT1-AS overexpression significantly suppressed the proliferation of U118 cells as demonstrated by CCK-8 assay.
      EdU incorporation ratios were significantly lower in WT1-AS plasmid transfected U118 cells compared to control cells (P < 0.001).
      WT1-AS overexpression significantly inhibited U118 cell migration and invasion (P < 0.001).
      The proportion of viable U118 cells transfected with WT1-AS was significantly lower when treated with temozolomide compared to control cells.
      The IC50 value of temozolomide was significantly reduced in WT1-AS overexpression U118 cells (P < 0.01).
    foundIn: "results"
    contextSnippet: "The CCK-8 assay demonstrated that overexpression of WT1-AS significantly suppressed the proliferation of U87 and U373 cells... overexpression of WT1-AS significantly inhibited glioma cell migration and invasion"
    confidence: 0.95
    doi: "10.1177/1533033820919759"

  - resourceName: "U251"
    resourceType: "Cell Line"
    observationType: "Cellular"
    observationTypeOntologyId: "MP:0005384"
    details: |
      WT1-AS expression was decreased in U251 glioma cell line compared to M059J normal astrocytes.
      miR-494-3p expression was increased in U251 glioma cell line compared to M059J normal astrocytes.
    foundIn: "results"
    contextSnippet: "We then examined WT1-AS expression in 4 glioma cell lines (U87, U118, U251, and A172). As compared to M059J, WT1-AS expression was decreased in these glioma cell lines"
    confidence: 0.90
    doi: "10.1177/1533033820919759"

  - resourceName: "A172"
    resourceType: "Cell Line"
    observationType: "Cellular"
    observationTypeOntologyId: "MP:0005384"
    details: |
      WT1-AS expression was decreased in A172 glioma cell line compared to M059J normal astrocytes.
      miR-494-3p expression was increased in A172 glioma cell line compared to M059J normal astrocytes.
    foundIn: "results"
    contextSnippet: "We then examined WT1-AS expression in 4 glioma cell lines (U87, U118, U251, and A172). As compared to M059J, WT1-AS expression was decreased in these glioma cell lines"
    confidence: 0.90
    doi: "10.1177/1533033820919759"

  - resourceName: "M059J"
    resourceType: "Cell Line"
    observationType: "Cellular"
    observationTypeOntologyId: "MP:0005384"
    details: |
      M059J normal human astrocytes served as control cell line with higher WT1-AS expression compared to glioma cell lines (U87, U118, U251, A172).
      M059J showed lower miR-494-3p expression compared to glioma cell lines.
    foundIn: "results"
    contextSnippet: "As compared to M059J, WT1-AS expression was decreased in these glioma cell lines... As compared to M059 J, miR-494-3p expression was decreased in these glioma cell lines"
    confidence: 0.90
    doi: "10.1177/1533033820919759"

  - resourceName: "pcDNA vector"
    resourceType: "Genetic Reagent"
    observationType: "Usage Instructions"
    observationTypeOntologyId: ""
    details: |
      The human lncRNA WT1-AS was successfully cloned into pcDNA vector for overexpression studies.
      WT1-AS expression was markedly increased in both U87 and U118 cells at 48-hour post-transfection with pcDNA-WT1-AS plasmid compared to control cells (P < 0.001).
    foundIn: "results"
    contextSnippet: "The human lncRNA WT1-AS were cloned into plasmid cloning DNA (pcDNA) vector... Quantitative real time polymerase chain reaction assays showed that WT1-AS expression was markedly increased"
    confidence: 0.95
    doi: "10.1177/1533033820919759"

  - resourceName: "pmirGLO vector"
    resourceType: "Genetic Reagent"
    observationType: "Usage Instructions"
    observationTypeOntologyId: ""
    details: |
      The WT1-AS sequence including putative binding sites of miR-494-3p was successfully subcloned into pmirGLO vector to generate wild-type WT1-AS (WT1-AS-WT) and mutant WT1-AS (WT1-AS-MUT) vectors.
      miR-494-3p significantly decreased the luciferase activity of WT1-AS-WT but had no effect on WT1-AS-MUT in luciferase reporter assay (P < 0.001).
    foundIn: "results"
    contextSnippet: "The WT1-AS sequence including the putative binding sites of miR-494-3p was subcloned and then inserted into the pmirGLO vector... luciferase reporter assay revealed that miR-494-3p significantly decreased the luciferase activity"
    confidence: 0.95
    doi: "10.1177/1533033820919759"

  - resourceName: "DIANA Tools"
    resourceType: "Computational Tool"
    observationType: "Usage Instructions"
    observationTypeOntologyId: ""
    details: |
      DIANA Tools successfully predicted binding sites between WT1-AS and miR-494-3p.
      The bioinformatics prediction was validated experimentally through luciferase reporter assays and RNA immunoprecipitation assays.
    foundIn: "results"
    contextSnippet: "Based on the prediction from DIANA Tools, miR-494-3p was predicted binding with WT1-AS... Then luciferase reporter assay revealed that miR-494-3p significantly decreased the luciferase activity"
    confidence: 0.90
    doi: "10.1177/1533033820919759"

summary:
  totalToolsMined: 0
  toolsAccepted: 0
  toolsRejected: 0
  toolsUncertain: 0
  potentiallyMissedCount: 19
  newPatternsCount: 7
  observationsExtracted: 8
  observationsByType:
    Cellular: 5
    Usage Instructions: 3
  majorIssuesFound: |
    - Complete failure of mining system to detect any tools despite this being a typical molecular biology study
    - Multiple cell lines (U87, U118, U251, A172, M059J) with vendor information completely missed
    - Numerous antibodies with vendor information not captured (p-AKT, total AKT, β-Actin, Ago2)
    - Multiple genetic reagents and kits with vendor details missed (TRIzol, lipofectamine, SYBR, mirVana, CCK-8, EdU, pcDNA, pmirGLO)
    - Computational tools (DIANA Tools, SPSS) not detected
    - Mining patterns appear to be inadequate for standard molecular biology terminology
  recommendations: |
    - All 19 potentially missed tools should be added to the database as they represent genuine research tools used in this study
    - The mining system requires significant improvement to capture standard molecular biology tools
    - Implement the 7 suggested patterns to improve future mining accuracy
    - Cell line nomenclature patterns need to be added (alphanumeric patterns like U87, U118, etc.)
    - Vendor information in parentheses should be a strong indicator of research tools
    - Context phrases like "antibodies against", "commercially procured from", "using the" should trigger tool detection
    - This publication demonstrates a systematic failure of the current mining approach for molecular biology studies
    - Manual curation is essential for this type of laboratory research publication
    - The 8 extracted observations provide valuable functional data about the validated tools
